You just read:

DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Component of Combination Chemotherapy Regimens for the Treatment of Solid Tumors including Brain and Ovarian Cancer

News provided by

DelMar Pharmaceuticals, Inc.

Oct 31, 2017, 05:30 ET